BioCentury
ARTICLE | Company News

Abpro, Essex Bio-Technology Ltd. deal

April 11, 2016 7:00 AM UTC

Abpro partnered with Essex to co-develop and commercialize mAbs in immune-oncology and ophthalmology using Abpro’s DiversImmune discovery platform. Abpro received a $3.5 million equity investment from...